• Profile
Close

Identifying BWH stage T2a cutaneous squamous cell carcinoma at risk for poor outcomes

Journal of the American Academy of Dermatology Dec 06, 2021

Gupta N, Weitzman RE, Murad F, et al. - Findings demonstrate an 8% likelihood of developing poor outcomes in Brigham and Women’s Hospital (BWH) T2a-high cutaneous squamous cell carcinomas (CSCCs).

  • In this 17-year retrospective multi-institutional cohort analysis of primary CSCC BWH T2a tumors, a predictive model based on tumor features was constructed to detect those at higher risk of poor outcomes.

  • Having 1 major and ≥1 minor criteria was most predictive of developing poor outcomes (AUC 0.53, C-statistic 0.60).

  • Major criteria included primary tumor diameter ≥40mm, invasion depth beyond subcutaneous fat, poor differentiation, and large caliber perineural invasion (PNI), and minor criteria were invasion depth in subcutaneous fat, moderate differentiation, small caliber PNI and lymphovascular invasion.

  • A sensitivity, specificity, and positive and negative predictive values of 7.7%, 97.4%, 33.3% and 86.1%, respectively, were demonstrated by the model.

  • In these tumors, 5-year cumulative incidence of poor outcomes was 8.0%, vs 2.8% in other T2a tumors (SHR 3.0).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay